| Filed On | Filing |
|---|---|
| 28 Oct 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, October 28, 2026— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). Unless otherwise noted, percentage a... |
| 25 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 24, 2026, Mr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc. (the "Company"), informed the Company of his decision to resign, effective November 1, 2026. Mr. Vandervoort's resignation was made... |
| 31 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
This Employment Agreement (“Agreement”) is made effective as of August 31, 2026 (“Effective Date”), by and between Teladoc Health, Inc. (the “Company”) and Mr. Michael Grasher, an individual resident in the State of [**] (“Executive”); and |
| 13 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of September 30, 2026. Mr. Snow has been a director of the Company since 2014 and the Company... |
| 03 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, August 3, 2026 -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating offic... |
| 29 Jul 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, July 29, 2026— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise noted, percentage and othe... |
| 21 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Teladoc Health, Inc. (the “Company”) was held on May 21, 2026. The Company previously filed with the Securities and Exchange Commission a definitive proxy statement and re... |
| 29 Apr 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, April 29, 2026— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 (“First Quarter 2026”). Unless otherwise noted, percentage and oth... |
| 30 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, March 30, 2026 -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN... |
| 25 Feb 2026 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, February 25, 2026— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31,... |
| 18 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
NEW YORK, February 18, 2026 -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial... |
| 12 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 8, 2026, Mr. Thomas G. McKinley notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of February 20, 2026. Mr. McKinley has been a director of the Company since 2009 and the Com... |
| 16 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On December 11, 2025, Mr. J. Eric Evans notified Teladoc Health, Inc. (the “Company”) of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board e... |
| 12 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
The 2023 Employment Inducement Incentive Award Plan (the “Plan”) of Teladoc Health, Inc., a Delaware corporation (the “Company”), is hereby amended, effective as of December 9, 2025 (the “Effective Date”), as follows: |
| 29 Oct 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, October 29, 2025— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percenta... |
| 23 Oct 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook |
| 29 Jul 2025 |
8-K: Results of Operations and Financial Condition
NEW YORK, NY, July 29, 2025— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 (“Second Quarter 2025”). Unless otherwise noted, percentage and ... |
| 23 Jul 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
JPMORGAN CHASE BANK, N.A., CITIBANK, N.A., WELLS FARGO BANK, NATIONAL ASSOCIATION, TRUIST SECURITIES, INC. AND ROYAL BANK OF CANADA |
| 23 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
The 2023 Incentive Award Plan (the “Plan”) of Teladoc Health, Inc., a Delaware corporation (the “Company”), is hereby amended, subject to the approval of the Company’s shareholders, effective as of May 22, 2025 (the “Amendment Effective ... |
| 30 Apr 2025 |
8-K: Results of Operations and Financial Condition
PURCHASE, NY, April 30, 2025— Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 (“First Quarter 2025”). Unless otherwise noted, percentage and... |
Loading...